<DOC>
	<DOCNO>NCT00852592</DOCNO>
	<brief_summary>The purpose study understand efficacy light therapy bipolar depression .</brief_summary>
	<brief_title>Light Therapy Bipolar Disorder . Efficacy Light Therapy Bipolar Depression : A Randomized Controlled Trial</brief_title>
	<detailed_description>Bipolar Disorders ( BD ) associate chronic depression , disability , increase suicide risk . Building early finding , conduct 6-week randomize , double-blind , placebo-controlled trial investigate efficacy midday light therapy bipolar depression . The aims examine change depression level proportion patient respond remit . We assess predictor response measure side effect , sleep quality , suicidality , psychosocial functioning . We include depressed adult BD-Type I II confirm SCID interview take stable-dosed antimanic medication . We exclude patient psychosis , rapid cycling , obsessive compulsive disorder , alcohol substance use disorder , hypomania mania , severe suicidality . Patients randomized 7000 lux broad spectrum light therapy OR 50 lux dim red light 45-60 minute daily . Weekly , blinded-clinician assess symptom Structured Interview Guide Hamilton Depression Scale Atypical Depression Supplement ( SIGH-ADS ) global functioning .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Ages 1865 year DSMIV Criteria BD I II depressive episode , SIGHADS &gt; 20 ; duration &gt; 2 week . Stable dose antidepressant drug &gt; 8 week concurrent antimanic drug Controlled thyroid disease Subjects preexist eye disease include . Able provide inform consent Stable minimum dose antimanic drug &gt; 4weeks : lithium 0.5 mEq/L , divalproex Na 50 mcg/mL , olanzapine 5mg daily , carbamazepine 4mg/L ; lamotrigine 100mg daily , risperidone 2mg daily , quetiapine 400 mg daily , ziprasidone 10 mg bid , aripiprazole 5 mg qd . Stable unchanged psychotherapy &gt; 16weeks The following eye disease : retinal disease , cataract surgery lens removal , macular degeneration , Taking photosensitize drug phenothiazine ( chlorpromazine ) , antimalarial drug , melatonin hypericum . Acute psychosis ( DSMIV Criteria ) Rapid cycle past 1 year Obsessive compulsive disorder Alcohol substance abuse dependence past 6 month . MRS &gt; 5 Recent history suicide attempt ( 3 month ) active suicidal Ideation ( SIGHADS item H11 &gt; 2 ) Betaadrenergic blocker , exogenous melatonin , chronic NSAIDS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Bipolar Disorder Depression Midday Light Therapy</keyword>
	<keyword>Bipolar Disorder Type I II</keyword>
</DOC>